Inflammatory Biomarkers to Detect Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Lung Cancer Patients

• Mandar A. Aras, MD, PhD,
• John R. Power, MD,
• Javid J. Moslehi, MD

Affiliations

Mandar A. Aras, MD, PhD

Division of Cardiology, University of California-San Francisco, San Francisco, California, USA

John R. Power, MD

Cardio-Oncology Program, Divisions of Cardiovascular Medicine and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Javid J. Moslehi, MD

Cardio-Oncology Program, Divisions of Cardiovascular Medicine and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Address for correspondence: Dr. Javid J. Moslehi, Cardio-Oncology Program, Vanderbilt School of Medicine, 2220 Pierce Avenue, 383 PRB, Nashville, Tennessee 37232-6300.